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 5q31 linked corneal dystrophies are a clinically and his-
tologically heterogeneous group of autosomal dominantly in-
herited corneal disorders. All these dystrophies result from
mutations in the Transforming Growth Factor Beta Induced
(TGFBI; BIGH3) gene, encoding for the BIGH3 protein, also
called keratoepithelin [1]. Corneal dystrophies caused by spe-
cific mutations of TGFBI include lattice corneal dystrophies
type I (LCDI), type IIIA (LCDIIIA), type I/IIIA (LCDI/IIIA),
and type IV(LCDIV), granular Groenouw type I corneal dys-
trophy (GCDI), Avellino corneal dystrophy (ACD), Thiel-
Behnke dystrophy or corneal dystrophy of Bowman layer type
II (CDB2), and Reis-Bücklers’ dystrophy (RBCD). The most
frequent types of these dystrophies result from mutations of
two mutational hot spots in exons 4 and 12 of the TGFBI gene,
representing codons 124 (LCDI, ACD, and RBCD) and 555
(GCD and CDB2), respectively. Mutations responsible for rare
lattice dystrophies (LCD types III and IV) localize to other
sites within exons 12, 13, and 14, encoding for the fourth
fasciclin1 domain of the BIGH3 protein [2,3]. Histological
examination of corneal specimens show amyloid deposits in
lattice dystrophies and Avellino dystrophy, hyaline accumula-
tion in granular dystrophy, and the presence of subepithelial
fibrous material in Reis-Bücklers and Thiel-Behnke dystro-
phy [4]. The two latter dystrophies, being relatively rare and
somewhat similar in clinical appearance, were not always
clearly distinguished in earlier studies [5,6]. However, the re-
cent literature revealed distinct genetic, morphological, and
clinical characteristics of these diseases. In Reis-Bücklers
dystrophy, caused by the R124L mutation, subepithelial geo-
graphic corneal deposits can be seen on clinical examination,
and rod shaped bodies can be observed by electron micros-
copy. Thiel-Behnke dystrophy, caused by the R555Q muta-
tion, is characterized by honeycomb-shaped subepithelial de-
posits, which are composed of curly filaments as shown by
electron microscopy [7,8].
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Purpose: To identify mutations in the Transforming Growth Factor Beta Induced (TGFBI) gene in Hungarian patients
with corneal dystrophy and to characterize histological features of their corneal buttons excised during penetrating kerato-
plasty.
Methods: Exons of TGFBI were sequenced in 38 members of 15 unrelated families with corneal dystrophy and exon 12
was also sequenced in 100 healthy controls from the same population. Immunohistological analysis of available corneal
buttons excised during penetrating keratoplasty was also performed.
Results: Molecular genetic analysis revealed a heterozygous R124C mutation in 18 patients with lattice type I dystrophy.
A R555W heterozygous mutation was detected in five patients with granular Groenouw type I corneal dystrophy and a
R555Q heterozygous mutation was found in four patients clinically diagnosed with Reis-Bücklers (one patient) and Thiel-
Behnke (three patients) dystrophy. Three patients with “atypical granular” dystrophy later diagnosed as Avellino dystro-
phy were heterozygous for the R124H mutation. A novel heterozygous mutation (T1640C) causing a F547S amino acid
exchange was detected in a patient with polymorphic corneal amyloidosis. Immunohistochemistry showed the presence
of BIGH3 protein deposits in all examined corneal buttons. Electron microscopy confirmed the presence of amyloid
fibrils in the case of the novel mutation.
Conclusions: Our results indicate that molecular genetic analysis is required to confirm the diagnosis of corneal dystro-
phies. We report the first cases of Avellino dystrophy from Central-Eastern Europe. We conclude that the novel F547S
mutation causes polymorphic corneal amyloidosis since no other mutations were detected in the TGFBI gene of this
patient and the novel mutation could not be found in healthy controls.
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TABLE 1. PRIMERS USED FOR SEQUENCING EXONS OF TGFBI
                                             Annealing     product
                                             temperature   length
Exon    primer            Sequence              (°C)        (bp)
----   --------   ------------------------   -----------   -------
1      forward:   5-CCCTCCCGCTCGCAGCTTAC-3       55          424
       reverse:   5-CCCTCTCTCCTTCCACCGCG-3
2      forward:   5-GACCCAAGGAGGCAAACACG-3       55          232
       reverse:   5-CCAGCGTGCATACAGCTTGG-3
3      forward:   5-CTCTTCCTTGGCTGTGGAGG-3       55          228
       reverse:   5-TCCTCTCTCCCACCATTCCC-3
4      forward:   5-CCCCAGAGGCCATCCCTCCT-3       58          226
       reverse:   5-CCGGGCAGACGGAGGTCATC-3
5      forward:   5-TCACGAGGGCTGAGAACATG-3       55          341
       reverse:   5-CAGAAACCAGCCCACACATG-3
6      forward:   5-GCTTTGGGACTATGCCTCTG-3       58          260
       reverse:   5-CTCTTGGGAGGCAATGTGTC-3
7      forward:   5-GAGCTTGGGTTTGGCTTCTG-3       55          350
       reverse:   5-AGCAGGTCTTGGGCTCAATC-3
8      forward:   5-GCTGCAAGTGGTCCCTGAGG-3       60          407
       reverse:   5-AGCTGTGAGCTGGGTCCAGG-3
9      forward:   5-TGCTGATGTGTGTCATGCCC-3       55          426
       reverse:   5-CCCAAAGGCATTCTCTGCAC-3
10     forward:   5-CCAAACTCAAGGAGGGATGG-3       58          373
       reverse:   5-CCTTCCTTGTCAGCAACCAG-3
11     forward:   5-CTGAACAAATCAGGAGGCCC-3       55          288
       reverse:   5-CTTGACAAATAGCTGGGGCC-3
12     forward:   5-TGTGCATTCCAGTGGCCTGG-3       55          339
       reverse:   5-GCCAACTGTTTGCTGCTGGG-3
13     forward:   5-GTGCTTATTCCCTGGGCAGG-3       55          317
       reverse:   5-ATATGTCCTGGAGCCCTGCC-3
14     forward:   5-TCGAGATCATGCCACTGCAC-3       55          344
       reverse:   5-TCTCCACCAACTGCCACATG-3
15     forward:   5-AGCCAGAAAGCCCACCAGTG-3       58          275
       reverse:   5-AGCAGCCAAGGAAGACAGGG-3
16     forward:   5-TCTGCCAAGGCCACCTGAGG-3       58          278
       reverse:   5-CAGCAGATGGCAGGCTTGGG-3
17/A   forward:   5-AGAGCATGGCAGAAGGAGGC-3       55          306
       reverse:   5-CCCACATGCACAAGGCTCAC-3
17/B   forward:   5-TACAGGAGGAATGCACCACG-3       55          376
       reverse:   5-AAACTGTGCCAGGACTTCCC-3
17/C   forward:   5-GACTGCCTATGCCAAGTCCC-3       58          364
       reverse:   5-AGGTGTGGAGGAGCATGACG-3
Primers have been optimized for PCR amplification of the 17 exons
of TGFBI from genomic DNA. In addition to entire exons, short seg-
ments of their flanking introns were also covered. Exon 17 was se-
quenced in three overlapping segments.
In several corneal dystrophies, the deposits contain the
BIGH3 protein as demonstrated by immunohistological ex-
amination [9,10].
In this study, we present the results of a molecular ge-
netic analysis of 15 families referred to our department be-
tween 1997 and 2006 because of presumed BIGH3-related
corneal dystrophies. Immunohistochemical studies of avail-
able dystrophic corneal buttons excised during penetrating
keratoplasty were performed using a polyclonal antibody de-
tecting the BIGH3 protein. The clinical and histological char-
acteristics of a corneal dystrophy similar to polymorphic cor-
neal amyloidosis, caused by the novel F547S mutation, are
described.
METHODS
Patients:  Thirty-eight members from 15 families that were
referred to the participating ophthalmology services between
1997 and 2006 were examined. One hundred unrelated, healthy
volunteers from the same population who showed no sign of
corneal disease on clinical examination were also recruited.
All examinations were performed according to the tenets of
the Declaration of Helsinki. All patients and controls were
enrolled in the study after informed consent.
Clinical examinations included assessment of best-cor-
rected visual acuity (BCVA), slit lamp examination, and slit
lamp photography. On clinical examination, 18 patients
showed the characteristics of lattice corneal dystrophy type I,
five patients had granular dystrophy Groenouw type I, one
patient was diagnosed with Reis-Bücklers, and three with
Thiel-Behnke dystrophy. Three patients had “atypical granu-
lar” dystrophy and one patient was diagnosed with “atypical
lattice” corneal dystrophy. Seven family members did not show
any clinical sign of corneal dystrophy.
Molecular genetic analysis:  Peripheral blood (9 ml) was
taken from patients, unaffected family members, and 100
healthy volunteers. Genomic DNA was isolated from buffy
coat using QIAamp DNA Blood Mini Kit (QIAGEN, Hilden,
Germany). Exons of TGFBI were amplified using polymerase
chain reaction (PCR) primers encompassing entire exons and
short segments of flanking introns. Exon 17 was sequenced in
three overlapping segments. Primers that we have optimized
for amplification are listed in Table 1. For exon 4, they are
identical to those previously published [1]. Primer annealing
temperature was adjusted separately for each PCR reaction
and ranged from 50 °C-60 °C. An initial step of denaturation
at 95 °C was followed by 35-45 cycles of annealing, elonga-
tion at 72 °C, and denaturation at 95 °C. PCR products puri-
fied by ultrafiltration were sequenced with an ABI Prism 310
Genetic Analyzer (Applied Biosystems, Foster City, CA).
Histology and immunohistochemistry:  Corneal buttons
of 15 patients affected by lattice corneal dystrophy type I
(LCDI; 10 cases from five families), corneal dystrophy of
Bowman layer type II (CDB2; two cases, one case initially
diagnosed as Reis-Bücklers dystrophy), Groenouw corneal
dystrophy type I (GCDI; two cases), and polymorphic corneal
amyloidosis (one case) were either fixed in 98% ethanol-2%
acetic acid solution and embedded in paraffin or frozen in
TissueTek OCT (Bayer, Pittsburgh, PA) and stored in liquid
nitrogen until use. One of the two CDB2 and GCDI corneal
buttons were recurrences 15 and 11 years after the first trans-
plantations, respectively. The patients with Avellino dystro-
phy had best corrected visual acuities between 20/30 and 20/
20, therefore keratoplasty was not performed and corneal but-
tons with Avellino dystrophy could not be subjected to histo-
logical analysis. Tissue sections were stained with hematoxy-
lin-eosin, congo red, and Masson’s trichrome in each case.
Congo red stained sections were examined under polarized
light as well. Polyclonal anti-BIGH3 antibody against an 18
amino-acid peptide identical with the NH2-terminal portion
of the protein was prepared in chickens as described [11]. Sec-
tions of corneal buttons were placed on β-methacrylopropyl-
trimetoxy-silane-coated glass slides (Sigma, Schnelldorf, Ger-
many), blocked with 5% horse serum, and then incubated with
1:100 diluted polyclonal antisera. Slides were developed with
Sigma Fast Red tablets (Sigma) according to the
manufacturer’s instructions. Slides were examined with a
Nikon Eclipse TS100 microscope (Nikon Instruments Europe
B.V., Badhoevedorp, Netherlands) with 20X and 40X objec-
tives.
Electron microscopy:  One-quarter of the corneal button
of the patient having the F547S mutation was fixed in 1%
glutaraldehyde, dehydrated in methanol, and embedded in
1977
Epon. Ultrathin sections were placed on coated 300 mesh cop-
per grids and post-contrasted in uranyl acetate-lead citrate.
Sections were examined with a Jeol 1010 transmission elec-
tron microscope at 80 kV.
RESULTS
 Results of genetic and immunohistochemical examinations
are summarized in Table 2. In all patients diagnosed with LCDI
dystrophy, the TGFBI R124C mutation was found. No muta-
tion in TGFBI was detected in seven clinically unaffected LCDI
family members. In five patients showing the clinical signs of
GCDI, the heterozygous R555W mutation was present. In one
patient initially diagnosed as having Reis-Bücklers dystrophy
and in three patients with CDB2 (Thiel-Behnke) dystrophy,
the heterozygous R555Q mutation was detected. Thus, the
diagnosis of Reis-Bücklers dystrophy was modified to CDB2
(Thiel-Behnke) dystrophy based on the results of the molecu-
lar genetic analysis.
Immunohistological examination of 10 LCDI corneal
buttons with a polyclonal antibody against the NH2-terminal
portion of the BIGH3 protein revealed strong staining of the
intraepithelial and subepithelial deposits and weaker staining
around deep stromal deposits while no labeling within the deep
deposits was observed (Figure 1A,B). Intra- or interfamilial
differences were not noted among LCDI patients. In GCDI
corneas, strong staining of the superficial and weaker staining
of the deep granular deposits was observed (Figure 1C,D). In
the CDB2 corneal buttons, strong labeling of the subepithelial
fibrous deposit could be detected (Figure 1E,F).
In three members of a family, clinical examinations re-
vealed breadcrumb-like deposits in the central anterior cor-
nea, which had linear extensions toward the deeper stroma.
Between the deposits, the cornea was clear. Based on the clini-
cal appearance, the initial diagnosis was “atypical granular”
dystrophy. Molecular genetic examination revealed the previ-
ously reported R124H mutation and established the diagnosis
of Avellino dystrophy.
In both corneas of a 46-year-old patient, slit lamp exami-
nation revealed central, snowflake-like deposits mixed with
fine linear and ice-chipped appearing deposits, which were
more abundant in the central than in the peripheral cornea.
Deposits were seen throughout the corneal stroma and numer-
ous pre-Descemet deposits could be observed, however, no
corneal guttae were present. A diffuse haze was seen between
the central corneal deposits (Figure 2A,B). The visual acuity
of the patient was 20/200 (right eye) and 30/200 (left eye). A
novel heterozygous mutation, T1640C, causing the F547S
amino acid exchange was detected in exon 12 of TGFBI in
this patient (Figure 2F). Histological examination of her cor-
neal button showed abundant congo red positive deposits
mainly in the deep layers of the corneal stroma (Figure 2C),
yielding green birefringence when examined under polarized
light (Figure 2D). Immunohistochemistry showed strong stain-
ing of the deposits after labeling with a polyclonal anti-BIGH3
antibody (Figure 2E). Electron microscopic examination de-
tected electron-dense deposits consisting of 8-10 nm thick,
straight, nonbranching fibrils among collagen lamellae of the
corneal stroma (Figure 3). All these findings indicate the pres-
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TABLE 2. RESULTS OF GENETIC AND HISTOLOGICAL EXAMINATIONS
                                                              Number
                                                               of
                    Molecular       Number                   corneal                    Immunohistology
   Clinical          genetic          of                     buttons                      (N-terminal
   diagnosis        diagnosis      patients     Mutation     examined   Deposit type        BIGH3)
---------------   --------------   --------   ------------   --------   -------------   ---------------
LCDI              LCDI                18         R124C          10      Amyloid         Intra- and
                                              heterozygous                              subepithelial
                                                                                        deposits
                                                                                        stained
GCDI              GCDI                 5         R555W           2      Hyaline         All deposits
                                              heterozygous                              stained
CDB1              CDB2                 1         R555Q           1      Subepithelial   All deposits
(Reis-Bücklers)   (Thiel-Behnke)              Heterozygous              acidophilic     stained
                                                                        fibers
CDB2              CDB2                 3         R555Q           1      Subepithelial   All deposits
(Thiel-Behnke)    (Thiel-Behnke)              heterozygous              acidophilic     stained
                                                                        fibers
Atypical          Avellino             3         R124H           -          -               -
granular                                      heterozygous
Atypical          Polymorphic          1         F547S           1      Amyloid         All deposits
lattice           corneal                     heterozygous                              stained
                  amyloidosis
Healthy family    Healthy family       7         None            -          -               -
member            member
The table summarizes clinical and genetic diagnoses as well as histological findings for 31 patients with dystrophic corneas and their 7 healthy
family members. Previously reported genotype-phenotype correlations have been confirmed. Clinical diagnosis had to be amended based on
genetic information in 4 cases (one Reis-Bücklers changed to Thiel-Behnke and 3 atypical granular to Avellino). A new mutation F547S was
found in a case of polymorphic corneal amyloidosis. Deposits in all dystrophic corneal buttons contained the NH3-terminal part of the BIGH3
protein.
1978
ence of BIGH3 containing amyloid deposits in the cornea of
this patient. The novel T1640C mutation was not detected in
the 100 unrelated healthy controls from the same population.
Therefore, we conclude that the T1640C mutation causing the
F547S amino acid exchange in the BIGH3 protein is respon-
sible for the corneal dystrophy of this patient.
DISCUSSION
 In accordance with many previous reports [12-15], we have
detected most of the mutations at codons 124 and 555 of
TGFBI, indicating that these sites represent mutational hot
spots in Hungarian corneal dystrophy patients as well. In four
cases, the initial clinical diagnosis had to be corrected based
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Figure 1. Histological examination of BIGH3-related corneal dystrophies.  A: A congo red-stained LCDI cornea is shown under polarized
light. Amyloid deposits are light green. B: Immuno-histological staining of an LCDI cornea with anti-BIGH3 antiserum is shown. Intra- and
subepithelial deposits show red staining. C: In a GCDI cornea, deposits appear bright red with Masson’s trichrome stain. D: Immuno-histo-
logical labeling of a cornea with recurrent GCDI shows the presence of BIGH3 protein in the deposits. E and F: Masson’s trichrome and
immuno-histological staining of a recurrent Thiel-Behnke dystrophy is illustrated. Subepithelially deposited fibrous material stains blue with
Masson’s trichrome and shows intensive immuno-labeling with the anti-BIGH3 antibody. Note that in E the epithelium is missing.
1979
on the results of the molecular genetic examinations. In one
case, initially diagnosed as Reis-Bücklers dystrophy, honey-
comb-shaped subepithelial deposits as well as characteristic
histological features of CDB2 were seen, thus the incorrect
diagnosis could have resulted from confusing earlier litera-
ture data [1,5,6], rather than an unusual clinical picture.
Different staining patterns of normal corneas and BIGH3
containing deposits were published with various antibodies
reacting with the NH2-terminal, COOH-terminal, or middle
portions of the BIGH3 protein [10,11,16]. Regarding LCDI
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Figure 2. Slit lamp and histological images of the polymorph corneal amyloidosis caused by the F547S mutation.  A and B: Clinical pictures
of the polymorph corneal amyloidosis caused by the F547S mutation shows a snowflake-like central and fine linear corneal deposits. Deposits
extend to the pre-Descemet level as shown in the photography with narrow slit (A). C: Congo red-stained cornea of the same patient shows
large congophilic deposits in the corneal stroma, which exhibit green birefringence when viewed under polarized light (D). E: Cornea of the
same patient, stained with anti-BIGH3 antibody, is shown in this section. All deposits are stained in red. F: The electropherogram of exon 12
of TGFBI of the same patient is shown. The arrow indicates the T>C heterozygous conversion at position 1640, causing the F547S amino acid
exchange.
1980
and GCDI, our findings corroborate earlier reports on the ab-
sence of NH2-terminal immuno-reactive BIGH3 in intrastro-
mal deposits. In CDB2, staining of the deposits has been re-
ported with an antibody to the middle portion of BIGH3 [9].
Our results indicate that CDB2 deposits also contain the NH2-
terminal segment of BIGH3.
In three members of one family, molecular genetic ex-
amination revealed the R124H mutation and established the
diagnosis of Avellino dystrophy, which has not been reported
from Hungary or the Eastern-European region so far. This type
of dystrophy was first described in an American-Italian fam-
ily [17] but was since found in many populations and seem to
be especially frequent in Asia [18-21]. Our study confirms
that the R124H mutation may occur in any population.
In a patient initially diagnosed as “atypical lattice” cor-
neal dystrophy, we detected the novel T1640C mutation caus-
ing the F547S amino acid exchange in BIGH3. No other mu-
tation in TGFBI could be detected in this patient. The novel
T1640C mutation was not found in 100 unrelated healthy sub-
jects from the same population, indicating that the mutation
does not represent a common polymorphism in Hungary. His-
tological and electronmicroscopic examination showed amy-
loid deposits in the corneal stroma, and immunohistochemis-
try showed the presence of BIGH3 in the patient’s corneal
deposits. These results indicate that T1640C is a novel muta-
tion of TGFBI causing corneal amyloidosis. This mutation
seems to be one of the rare mutations in the fourth fasciclin1
(FAS1) domain of BIGH3, which cause various forms of cor-
neal amyloidosis with characteristic lattice lines described as
LCDI, LCDI/IIIA, LCDIIIA, LCDIV, and polymorphic cor-
neal amyloidosis [3,22-28]. In 2003, Clout and Hohenester
[29] established a structural model of the fourth FAS1 domain
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Figure 3. Electron micrograph of the cor-
nea with the F547S mutation.  Top: Elec-
tron micrographs of the cornea of the pa-
tient with the F547S mutation shows a
large, electron-dense deposit (asterisk)
among the collagen lamellae (double as-
terisk). Bottom: At higher magnification,
nonbranching 8-10 nm fibrils are re-
vealed, indicating the amyloid nature of
the deposit.
1981
of BIGH3, based on the crystal structure of drosophila
fasciclin1. Using this model, they concluded that with the ex-
ception of R124 and R555, all amino acids implicated so far
in dystrophy-related mutation sites in BIGH3 are highly con-
served and probably have a role in protein folding and main-
tenance of protein structure. Phenylalanine 547 is located in a
10 amino acid long conserved region, which extends from
Y537 to F547 [30]. According to the model, F547 would in-
teract with L518 and other side chains in the formation of a
buried hydrophobic protein core. The exchange of the hydro-
phobic phenylalanine in position 547 to serine, a hydrophilic
and much smaller molecule, could disrupt this core and cause
severe structural instability and protein misfolding. Interest-
ingly, five mutations have been described in the conserved
region between Y537 and F547, three of them (T538R, F540S,
and A546T) causing LCDIIIA [3,31,32], one (N544S) caus-
ing LCDIV [33], and another (A546D) causing polymorphic
corneal amyliodosis [34]. In the latter dystrophy, central de-
posits with chipped-ice appearance as well as fine, deep stro-
mal linear deposits were described, and histology showed the
presence of amyloid deposits in the corneal stroma. Because
of its comparable clinical and histological characteristics, we
have classified the dystrophy caused by the F457S mutation
as polymorphic corneal amyloidosis.
Collectively, our results demonstrate that molecular ge-
netic analysis is necessary to establish the appropriate diag-
nosis of corneal dystrophies. Detailed genetic and histologi-
cal characterization helps our understanding of the
pathomechanisms of TGFBI-related corneal dystrophies.
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